-
Posted by
Two Blokes Apr 23 -
Filed in
Stock
-
5 views
Denmark-based pharmaceutical giant Novo Nordisk (NVO 2.66%) has been struggling during the past year. Its financial results -- though strong by comparison to most of its peers -- haven't been as good as investors expected.
